Phyllis R Yale - Net Worth and Insider Trading

Phyllis R Yale Net Worth

The estimated net worth of Phyllis R Yale is at least $2 Million dollars as of 2024-04-27. Phyllis R Yale is the Director of DaVita Inc and owns about 13,110 shares of DaVita Inc (DVA) stock worth over $2 Million. Phyllis R Yale is also the Director of Kindred Healthcare Inc and owns about 44,633 shares of Kindred Healthcare Inc (KND) stock worth over $401,697. Details can be seen in Phyllis R Yale's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Phyllis R Yale has not made any transactions after 2023-05-12 and currently still holds the listed stock(s).

Transaction Summary of Phyllis R Yale

To

Phyllis R Yale Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Phyllis R Yale owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , DaVita Inc (DVA) , and Kindred Healthcare Inc (KND) .

Click here to see the complete history of Phyllis R Yale’s form 4 insider trades.

Insider Ownership Summary of Phyllis R Yale

Ticker Comapny Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2019-11-20 director
DVA DaVita Inc 2023-05-12 director
KND Kindred Healthcare Inc 2018-07-02 director

Phyllis R Yale Latest Holdings Summary

Phyllis R Yale currently owns a total of 2 stocks. Among these stocks, Phyllis R Yale owns 13,110 shares of DaVita Inc (DVA) as of May 12, 2023, with a value of $2 Million and a weighting of 81.33%. Phyllis R Yale also owns 44,633 shares of Kindred Healthcare Inc (KND) as of June 28, 2013, with a value of $401,697 and a weighting of 18.67%.

Latest Holdings of Phyllis R Yale

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DVA DaVita Inc 2023-05-12 13,110 133.51 1,750,316
KND Kindred Healthcare Inc 2013-06-28 44,633 9.00 401,697

Holding Weightings of Phyllis R Yale


Phyllis R Yale Form 4 Trading Tracker

According to the SEC Form 4 filings, Phyllis R Yale has made a total of 2 transactions in DaVita Inc (DVA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in DaVita Inc is the sale of 2,196 shares on May 12, 2023, which brought Phyllis R Yale around $209,191.

According to the SEC Form 4 filings, Phyllis R Yale has made a total of 0 transactions in Kindred Healthcare Inc (KND) over the past 5 years. The most-recent trade in Kindred Healthcare Inc is the acquisition of 8,000 shares on June 28, 2013, which cost Phyllis R Yale around $103,440.

Insider Trading History of Phyllis R Yale

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Phyllis R Yale Trading Performance

GuruFocus tracks the stock performance after each of Phyllis R Yale's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phyllis R Yale is 1.83%. GuruFocus also compares Phyllis R Yale's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phyllis R Yale within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Phyllis R Yale's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Phyllis R Yale

Average Return

78.14%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.1 1.83 50.11 78.14 27.06 -6.01
Relative Return to S&P 500(%) 7.79 -3.49 35.47 56.06 12.64 -14.23

Phyllis R Yale Ownership Network

Ownership Network List of Phyllis R Yale

No Data

Ownership Network Relation of Phyllis R Yale


Phyllis R Yale Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Phyllis R Yale is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Phyllis R Yale made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Phyllis R Yale Mailing Address

Above is the net worth, insider trading, and ownership report for Phyllis R Yale. Currently GuruFocus does not have mailing address information for Phyllis R Yale.

Discussions on Phyllis R Yale

No discussions yet.